The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults. Bamford AR, Adams JN, Kim S, McMillan LC, et al. Neurobiol Aging 2024;144:12-18.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bamford AR, Adams JN, Kim S, McMillan LC, et al. The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults. Neurobiol Aging 2024;144:12-18.
PMID: 39241563